Vincent Castonguay
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer Real-world data from 50 consecutive cases treated in a single Canadian center.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 17, 2026
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis.
Journal: Clinical genitourinary cancer
Published: December 16, 2025
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada.
Journal: Journal of geriatric oncology
Published: August 06, 2025
Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer.
Journal: BMC cancer
Published: June 17, 2025
Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report.
Journal: Current oncology (Toronto, Ont.)
Published: June 14, 2025
Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects.
Journal: Cancer discovery
Published: November 19, 2024
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: November 05, 2024
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study.
Journal: Clinical genitourinary cancer
Published: October 21, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.
Journal: Current oncology (Toronto, Ont.)
Published: July 28, 2024
Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 23, 2024
Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study.
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2024
Last Updated: 09/26/2026